StockData
Sangamo Therapeutics, Inc logo

Sangamo Therapeutics, Inc (SGMOQ) stock

SGMOQOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 14, 2026Score 4/30
$0.10−0.01 (-8.17%)

Close on Oct 19, 2026Market cap $39.43MP/E –Yield –

Sangamo Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Sangamo Therapeutics

Sangamo Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Sangamo Therapeutics figures

See a number that looks wrong?